IPSIndian Journal of Pharmacology
Home  IPS  Feedback Subscribe Top cited articles Login 
Users Online : 405 
Small font sizeDefault font sizeIncrease font size
Read this article


    Article Cited by others


Managing diabetic ketoacidosis in non-intensive care unit setting: Role of insulin analogs

Karoli R, Fatima J, Salman T, Sandhu S, Shankar R

Year : 2011| Volume: 43| Issue : 4 | Page no: 398-401

   This article has been cited by
1 The SQuID protocol (subcutaneous insulin in diabetic ketoacidosis): Impacts on ED operational metrics
Richard T. Griffey, Ryan M. Schneider, Margo Girardi, Julianne Yeary, Craig McCammon, Laura Frawley, Rachel Ancona, Paulina Cruz-Bravo
Academic Emergency Medicine. 2023;
[Pubmed]  [Google Scholar] [DOI]
2 Clinical and biochemical predictors of intensive care unit admission among patients with diabetic ketoacidosis
Adeel Ahmad Khan, Fateen Ata, Phool Iqbal, Mohammed Bashir, Anand Kartha
World Journal of Diabetes. 2023; 14(3): 271
[Pubmed]  [Google Scholar] [DOI]
3 Efficacy and Safety of Intravenous Insulin in Treatment of Patient With Diabetic Ketoacidosis: A Systematic Review and Meta-Analysis
Kareema S Alshurtan, Osama Alnizari, Hadi Aldarwish , Ali A Al-Tufaif
Cureus. 2022;
[Pubmed]  [Google Scholar] [DOI]
4 Evaluation of Outcomes Following Hospital-Wide Implementation of a Subcutaneous Insulin Protocol for Diabetic Ketoacidosis
Priya Rao, Sheng-fang Jiang, Patricia Kipnis, Divyesh M. Patel, Svetlana Katsnelson, Samineh Madani, Vincent X. Liu
JAMA Network Open. 2022; 5(4): e226417
[Pubmed]  [Google Scholar] [DOI]
5 Management of hospitalized patients with mild to moderate diabetic ketoacidosis using a continuous insulin infusion protocol on a medical surgical ward and observation level of care: A retrospective cohort study
Michael S. Yoo, Abraham Daniels, Rene A. Maslow, John A. Gomez, Nannette L. Meyers, Pamela S. Bohrer, Siamack Nemazie, Christina E. Sanford, Emily A. Peterson, Kendal L. Hamann, Darcy E. Walsh, Alison M. O’Herlihy, Vivek Kumra
Medicine. 2022; 101(31): e29665
[Pubmed]  [Google Scholar] [DOI]
6 Subcutaneous Rapid-acting Insulin Analogs for Diabetic Ketoacidosis
Lillian Chow, Walter Valesky, Shahriar Zehtabchi
Academic Emergency Medicine. 2021; 28(6): 700
[Pubmed]  [Google Scholar] [DOI]
7 Acidose métabolique
Audrey De Jong, Joris Pensier, Boris Jung, Fouad Belafia, Gérald Chanques, Samir Jaber
Anesthésie & Réanimation. 2021; 7(1): 35
[Pubmed]  [Google Scholar] [DOI]
8 Use of a Flexible Catheter for the Administration of Subcutaneous Insulin in Diabetic Ketoacidosis: A Feasibility Controlled Clinical Trial
Maria Laura Beaudoin, Milagros Torrents, María Florencia Tittarelli, Magali Hamui, Mariano Ibarra, Mabel Ferraro, Juan Pablo Ferreira
Hospital Pediatrics. 2021; 11(4): 396
[Pubmed]  [Google Scholar] [DOI]
9 Outcomes of diabetic ketoacidosis in a tertiary centre with restricted intensive care unit bed capacity
Iftach Sagy, Noa Zimhony-Nissim, Evgenia Brandstaetter, Inna Lipnitzki, Hadeel Musa, Yakov Rosen, Leonid Barski
Internal Medicine Journal. 2021; 51(6): 948
[Pubmed]  [Google Scholar] [DOI]
10 ISPAD Clinical Practice Consensus Guideline: Diabetic ketoacidosis in the time of COVID -19 and resource-limited settings-role of subcutaneous insulin
Leena Priyambada, Joseph I. Wolfsdorf, Stuart J. Brink, Maria Fritsch, Ethel Codner, Kim C. Donaghue, Maria E. Craig
Pediatric Diabetes. 2020; 21(8): 1394
[Pubmed]  [Google Scholar] [DOI]
11 Efficacy and Safety of Commonly Used Insulin Analogues in the Treatment of Diabetic Ketoacidosis: A Bayesian Indirect Treatment Comparison
Kota Vidyasagar, Boya Chandrasekar, Manik Chhabra, Anil Bhansali, Dipika Bansal
Clinical Therapeutics. 2020; 42(8): e115
[Pubmed]  [Google Scholar] [DOI]
12 Diabetic ketoacidosis
Ketan K. Dhatariya, Nicole S. Glaser, Ethel Codner, Guillermo E. Umpierrez
Nature Reviews Disease Primers. 2020; 6(1)
[Pubmed]  [Google Scholar] [DOI]
13 Reducing Diabetic Ketoacidosis Intensive Care Unit Admissions Through an Electronic Health Record-Driven, Standardized Care Pathway
Karli Edholm, Katie Lappé, Polina Kukhareva, Christy Hopkins, Nathan D. Hatton, Benjamin Gebhart, Heather Nyman, Emily Signor, Mikyla Davis, Kensaku Kawamoto, Stacy A. Johnson
Journal for Healthcare Quality. 2020; 42(5): e66
[Pubmed]  [Google Scholar] [DOI]
14 Diabetic Ketoacidosis in COVID-19: Unique Concerns and Considerations
Nadine E Palermo, Archana R Sadhu, Marie E McDonnell
The Journal of Clinical Endocrinology & Metabolism. 2020; 105(8): 2819
[Pubmed]  [Google Scholar] [DOI]
15 Subcutaneous rapid-acting insulin analogues for diabetic ketoacidosis
Carlos A Andrade-Castellanos, Luis Enrique Colunga-Lozano, Netzahualpilli Delgado-Figueroa, Daniel A Gonzalez-Padilla
Cochrane Database of Systematic Reviews. 2016; 2016(1)
[Pubmed]  [Google Scholar] [DOI]
16 Question 1: Treatment of mild to moderate ketoacidosis in children and adolescents with subcutaneous insulin
D. Mul,E. Molendijk
Archives of Disease in Childhood. 2015; 100(1): 106
[Pubmed]  [Google Scholar] [DOI]
17 Evaluation of Ward Management of Diabetic Ketoacidosis
Branden D. Nemecek, Kathie L. Hermayer, Pamela C. Arnold, Nicole M. Bohm
Clinical Diabetes. 2014; 32(3): 100
[Pubmed]  [Google Scholar] [DOI]
18 Treatment of diabetic ketoacidosis with subcutaneous insulin lispro: A review of the current evidence from clinical studies
M. Vincent,E. Nobécourt
Diabetes & Metabolism. 2013; 39(4): 299
[Pubmed]  [Google Scholar] [DOI]


Site Map | Home | Contact Us | Feedback | Copyright and Disclaimer | Privacy Notice
Online since 20th July '04
Published by Wolters Kluwer - Medknow